About Brian Struchtemeyer
Form D filings for Acenxion Biosytems from 2023 to 2024 list Brian Struchtemeyer as executive officer and director.
Brian Struchtemeyer first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Brian Struchtemeyer in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Brian Struchtemeyer works with at each company, as listed on that company's latest Form D.
Acenxion Biosytems, Inc. · Form D, Aug 14, 2024